Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
5.40
-0.21 (-3.74%)
Mar 25, 2025, 4:00 PM EST - Market closed
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $167.82 million as of March 25, 2025. Its market cap has increased by 47.40% in one year.
Market Cap
167.82M
Enterprise Value
-15.62M
1-Year Change
47.40%
Ranking
Category
Stock Price
$5.40
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $167.82M, a decrease of -28.62%. That is a compound annual growth rate of -13.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2025 | 174.67M | -6.81% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 774.44B |
| UnitedHealth Group | 470.01B |
| Johnson & Johnson | 394.54B |
| AbbVie | 361.91B |
| Novo Nordisk | 335.17B |
| Merck & Co. | 231.21B |
| AstraZeneca | 229.25B |
| Abbott Laboratories | 220.94B |